BRAF inhibitor (vemurafenib) concurrent with radiation therapy for metastatic melanoma producing severe skin and oral cavity reactions

Jonathan B. Wallach, Petra Rietschel, Shalom Kalnicki, Jana L. Fox

Research output: Contribution to journalArticle

4 Scopus citations
Original languageEnglish (US)
Pages (from-to)e213-e216
JournalPractical Radiation Oncology
Volume4
Issue number5
DOIs
StatePublished - Sep 1 2014

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this